Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,191	1,343	492	216	534	1,559
Market Cap Growth	39.54%	173.13%	127.16%	-59.47%	-65.74%	720.77%
Enterprise Value	1,842	991	464	155	413	1,546
Last Close Price	12.50	8.54	4.46	2.81	6.97	20.70
PS Ratio	37.35	21.07	8.41	4.20	12.27	89.57
PB Ratio	7.07	4.26	5.39	6.12	6.07	20.48
P/TBV Ratio	7.05	4.26	5.39	6.12	6.07	20.48
EV/Sales Ratio	32.50	15.54	7.94	3.01	9.50	88.85
Debt / Equity Ratio	0.25	0.24	0.92	1.82	0.67	0.77
Asset Turnover	0.12	0.18	0.29	0.29	0.19	0.10
Inventory Turnover	63.72	49.86	31.01	35.98	44.46	28.56
Quick Ratio	9.83	10.27	6.36	3.94	7.04	9.01
Current Ratio	10.10	10.66	6.66	4.13	7.26	9.23
Return on Equity (ROE)	-63.41%	-95.21%	-127.64%	-115.16%	-7.99%	-429.55%
Return on Assets (ROA)	-31.14%	-30.53%	-25.66%	-27.76%	-20.90%	-23.06%
Return on Capital (ROIC)	-36.09%	-38.31%	-37.56%	-39.86%	-34.65%	-41.29%
Earnings Yield	-10.05%	-14.41%	-16.42%	-32.83%	-1.23%	-9.98%
FCF Yield	-8.32%	-10.13%	-15.53%	-29.26%	-12.50%	-3.49%
Buyback Yield / Dilution	-46.67%	-84.90%	-3.57%	-0.59%	-35.24%	-34.19%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q